Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation
Status:
Terminated
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to test an experimental drug therapy called Tramadol
Hydrochloride (HCl) Orally Disintegrating Tablets (ODT) ("Tramadol HCl ODT" or the "study
drug"). The subject and his partner are being asked to be in this clinical trial because they
have a condition called premature ejaculation.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.